Start free trial →
Setup help15 minutes, with a human, free.Built for US independent pharmaciesNo contract, no lock-inLess than 24 hr support response, every timeCancel in one clickStart free trial →Start trial →
Menu
Language
Still managing receipts manually?
AI-powered automation • Start saving time today
Start free trial
4
Rules in this policy
$50
Receipt threshold
$2,500
Sign-off above this

Why DIR Fees Make Expense Forecasting Hard

A practical, data-backed guide to controlling costs and automating expense workflows.

Use this as your expense policy
and easily manage employee travel and expenses
No credit card · every rule editable after · cancel in one click
Try it here · no sign-up
No card · 15-minute setup · keep your cards

DIR fees, primarily collected by PBMs from pharmacies, can make expense forecasting difficult due to the lack of transparency and the varying rates applied. These fees, which are price concessions collected from pharmacies, were mandated by CMS rule CMS-4192-F in January 2024 as a way to increase transparency and challenge persistent challenges. As a result, pharmacies have been required to apply most price concessions at the point of sale, increasing the complexity of expense forecasting. For the bigger picture, see our guide to independent pharmacies expense management software. For a complete overview, see our expense management guide.

Incurdesk expense report "Overview of the whole article: Why DIR Fees Make Expense Forecasting Hard" with columns [, 1, ,,
Overview of the whole article: Why DIR Fees Make Expense Forecasting Hard (sample data)
Policy template · Independent pharmacies
Why DIR Fees Make Expense Forecasting Hard

The rules in this guide

AmountRequiredIn Incurdesk
Above $50Itemised receiptChecked on every expense
Above $150Written business purposeChecked on every expense
Above $250Names of attendeesChecked on every expense
Above $2,500Senior sign-off; never auto-approvedChecked on every expense
incurdesk.com/user/app/policy/
Product screenshot. The same thresholds as a live policy in Incurdesk. Each number above is a field here, and three of them are checked when an expense is submitted.
incurdesk.com/user/app/submit/
Product screenshot. A $320 team dinner checked against this policy as it is submitted: receipt and purpose pass, attendees still missing.
Your policy, ready to use
Put this policy to work
Receipt above $50Purpose above $150Attendees above $250Never auto-approved above $2,500

Each rule is checked on every expense by Incurdesk’s approval agent.

Use this policy →Free account · every number editable · cancel in one click
Calculate Your Savings
Interactive
Calculate your savings
Hours saved/yr
218
Annual savings
$10,900
Incurdesk cost/yr
$5,700
Net ROI: +$5,200/year
Where 4.2 hours go weekly
Time savings with Incurdesk

DIR Fees: A Growing Concern for Independent Pharmacies

DIR fees are a growing concern for independent pharmacies. While some pharmacies may not have incurred significant fees, others have reported annual fee clawbacks exceeding $100,000. The high fees have led to a decrease in the number of pharmacies operating, with over 2,200 closing nationwide between 2017 and 2020. In 2026, pharmacies using the accrual method of accounting may face a mismatch between recognized revenue and eventual collection, as retroactive fee assessments can create uncertainty.

For pharmacies relying on the accrual method of accounting, retroactive fee assessments can create a financial strain. The fees are typically applied at the point of sale, but pharmacies may not receive payment until they collect the prescriptions. This can lead to a delayed receipt of payment, causing a delay in cash flow for the pharmacy. To mitigate these risks, pharmacies may need to adjust their accounting practices, such as increasing their inventory levels or adjusting their pricing strategies.

Keeping this simple: Incurdesk turns submitted expenses into clean expense reports. It is built for small independent pharmacy teams. Try it free.

Navigating the Changing Landscape of DIR Fees and PBM Regulations

While the point of sale (POS) rule has increased transparency, a growing number of pharmacy closures and financial strain are consequences.

Performance-based network fees under commercial and Medicaid PBM contracts fall outside the scope of the POS rule. This means that some pharmacies may continue to face additional revenue reductions, even after the POS rule takes effect.

Some states have enacted their own laws that may further restrict PBM fees or increase transparency in commercial contracts. While this law does not specifically address DIR fees, it highlights the ongoing efforts to increase transparency and accountability in the PBM industry.

As the landscape of DIR fees and PBM regulations continues to evolve, it is essential for pharmacies to stay informed and adapt to these changes. This may involve:

  • Regularly reviewing and adjusting pricing strategies to ensure compliance with changing regulations
  • Monitoring state-specific laws and regulations affecting PBM fees
  • Considering alternative reimbursement models or pricing structures
  • Staying up-to-date on industry developments and best practices
Adopt this policy in your accountEvery threshold in this guide becomes a rule Incurdesk’s approval agent checks on each expense.
Use this policy →

Why DIR Fees Make Expense Forecasting Hard

Retroactive DIR fees for prescriptions dispensed before January 1, 2024, continue to impact pharmacy finances. In 2024, these fees were assessed at an estimated 5.5% of gross revenue. This increase is largely due to the development of new audit triggers and reimbursement models by PBMs to recoup revenue previously captured through retroactive fees.

In 2020, DIR fees averaged 2.5% of gross revenue. This benchmark provides a clear understanding of the current state of DIR fees. While some pharmacies may have been able to manage their expenses with the lower fees, the new audit triggers and reimbursement models will require pharmacies to adjust their pricing strategies.

As a result, pharmacies may need to increase their pricing to cover the increased costs. This could lead to a shift towards more expensive products, which may not be feasible for all pharmacies. The impact of DIR fees on pharmacy finances will continue to be felt in 2024 and beyond.

Understanding the Impact of DIR Fees on Pharmacy Finances

Many pharmacy financials have been impacted by the DIR fees, primarily from Medicare Part D. The CMS rule (CMS-4192-F) mandates that nearly all pharmacy price concessions must be applied at the point of sale. This means that pharmacies must now account for the fees collected by PBMs in their expense forecasting.

The DIR fees are calculated as a percentage of pharmacy gross revenue. In 2020, the average DIR fee for pharmacies was 2.5% of gross revenue.

The DIR fees can add up quickly, especially for small independent pharmacies with lower revenue. In 2023, the estimated DIR fee for pharmacies was 5.5% of gross revenue, which is significantly higher than the 2.5% average in 2020.

Without the point-of-sale price concessions, pharmacies would need to adjust their expense forecasting to account for the additional fees. This can be challenging, especially for small pharmacies with limited financial resources.

To navigate the changing landscape of DIR fees and PBM regulations, pharmacies must stay informed about the specific terms, performance metrics, and fee structures used by PBMs. This includes understanding the laws and regulations that govern DIR fees, as well as the potential impacts on pharmacy finances.

Frequently Asked Questions
What are DIR Fees and How Do They Affect My Pharmacy's Revenue?
DIR fees, primarily from Medicare Part D, are price concessions collected by PBMs from pharmacies. While the January 1, 2024, CMS rule mandates most price concessions be applied at the point of sale (POS), increasing transparency, challenges persist. The POS rule only applies to Medicare Part D; commercial and Medicaid contracts are excluded.
How Can I Accurately Forecast My Pharmacy's Revenue When Performance Metrics Still Affect My Reimbursement?
Accurate forecasting requires detailed data analysis, including information on pharmacy profitability, cash flow, and PBM contracts. To accurately forecast revenue, pharmacies should review their PBM contracts, cash flow projections, and performance metrics to identify areas where DIR fees may be impacting their profitability. By understanding these factors, pharmacies can develop a more accurate forecast and make data-driven decisions to optimize their pricing and operations.
IN
About Incurdesk

AI expense management for finance teams and whoever keeps the books. It checks every expense against your rules, approves the routine ones and chases missing receipts for you.

Try it free for 30 days →

Stop losing 4+ hours a week

30-day free trial · No credit card · Setup in 15 minutes